eli lilly glp 1 stock analysis is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Eli Lilly vs Novo Nordisk:

Most studies show no major change in clearance, but patients with kidney or liver problems should be monitored closely to avoid the risk of any side effects

The balance requires individualised assessment, taking into account your baseline metabolic rate, activity level, treatment goals, and overall health status

You can eat spinach, kale, broccoli, carrots, cucumbers, bell peppers, zucchini, etc

Legal analysts estimate total liability across all GLP-1 manufacturers could exceed $2 billion, though no global settlements have been reached as of November 2025

I have lost 25 pounds so far! Mike S

Side effects like nausea, gallbladder issues, or rare pancreatitis can still occur at lower doses